(2) DEFINITION; CONFORMING AMENDMENTS.— 
The Controlled Substances Act (21 U.S.C. 801 et 
seq.) is amended— 
(A) in section 102— 
(i) by striking paragraph (45); and 
(ii) by redesignating paragraph (46) 
as paragraph (45); 
(B) in section 204(e), by striking ‘‘shall’’ 
the first time it appears and inserting ‘‘may’’; 
and 
(C) in section 310(b)(3)(D)(ii), by striking 
‘‘102(46)’’ and inserting ‘‘102(45)’’. 
(c) PUBLIC LAW 104–237.—Section 401 of the Com-
prehensive Methamphetamine Control Act of 1996 (21 
U.S.C. 802 note) (Public Law 104–237) is amended by 
striking subsections (d), (e), and (f). 
(d) COMBINATIONS INVOLVING DERIVATIVES.—Sec-
tion 102(39) of the Controlled Substances Act (21 U.S.C. 
802(39)) is amended— 
(1) in subparagraph (A)(iv)(I)(aa), by striking 
‘‘the drug contains’’ and all that follows through 
‘‘unless otherwise provided’’ and inserting the fol-
lowing: 
‘‘the 
drug 
contains 
ephedrine, 
pseudoephedrine, or phenylpropanolamine unless 
otherwise provided’’; and
(2) by inserting after and below subparagraph 
(B) the following: 
‘‘Each reference in subparagraph (A)(iv) to ephedrine, 
pseudoephedrine, or phenylpropanolamine includes each of 
the salts, optical isomers, and salts of optical isomers of 
such chemical.’’. 
SEC. 
102. 
AUTHORITY 
TO 
ESTABLISH 
PRODUCTION 
QUOTAS. 
Section 306 of the Controlled Substances Act (21 
U.S.C. 826) is amended— 
(1) in subsection (a), by inserting ‘‘and for 
ephedrine, pseudoephedrine, and phenylpropanola-
mine’’ after ‘‘for each basic class of controlled sub-
stance in schedules I and II’’; 
(2) in subsection (b), by inserting ‘‘or for 
ephedrine, pseudoephedrine, or phenylpropanola-
mine’’ after ‘‘for each basic class of controlled sub-
stance in schedule I or II’’ each place such term ap-
pears; 
(3) in subsection (c), in the first sentence, by 
inserting ‘‘and for ephedrine, pseudoephedrine, and 
phenylpropanolamine’’ after ‘‘for the basic classes of 
controlled substances in schedules I and II’’;
(4) in subsection (d), by inserting ‘‘or ephed-
rine, pseudoephedrine, or phenylpropanolamine’’ 
after ‘‘that basic class of controlled substance’’; 
(5) in subsection (e), by inserting ‘‘or for 
ephedrine, pseudoephedrine, or phenylpropanola-
mine’’ after ‘‘for a basic class of controlled sub-
stance in schedule I or II’’ each place such term ap-
pears; 
(6) in subsection (f)— 
(A) 
by 
inserting 
‘‘or 
ephedrine, 
pseudoephedrine, 
or 
phenylpropanolamine’’ 
after ‘‘controlled substances in schedules I and 
II’’; 
(B) 
by 
inserting 
‘‘or 
of 
ephedrine, 
pseudoephedrine, 
or 
phenylpropanolamine’’ 
after ‘‘the manufacture of a controlled sub-
stance’’; and 
(C) by inserting ‘‘or chemicals’’ after 
‘‘such incidentally produced substances’’; and 
(7) by adding at the end the following sub-
section: 
‘‘(g) Each reference in this section to ephedrine, 
pseudoephedrine, or phenylpropanolamine includes each of 
the salts, optical isomers, and salts of optical isomers of 
such chemical.’’.
SEC. 103. PENALTIES; AUTHORITY FOR MANUFACTURING; 
QUOTA. 
Section 402(b) of the Controlled Substances Act (21 
U.S.C. 842(b)) is amended by inserting after ‘‘manufac-
ture a controlled substance in schedule I or II’’ the fol-
lowing: ‘‘, or ephedrine, pseudoephedrine, or phenyl-
propanolamine or any of the salts, optical isomers, or salts 
of optical isomers of such chemical,’’. 
SEC. 104. RESTRICTIONS ON IMPORTATION; AUTHORITY TO 
PERMIT IMPORTS FOR MEDICAL, SCIENTIFIC, 
OR OTHER LEGITIMATE PURPOSES. 
Section 1002(a) of the Controlled Substances Import 
and Export Act (21 U.S.C. 952(a)) is amended— 
(1) in the matter preceding paragraph (1), by 
inserting ‘‘or ephedrine, pseudoephedrine, or phenyl-
propanolamine,’’ after ‘‘schedule III, IV, or V of title 
II,’’; 
(2) in paragraph (1), by inserting ‘‘, and of 
ephedrine, pseudoephedrine, and phenylpropanola-
mine, ’’ after ‘‘coca leaves’’; and 
(3) by adding at the end the following sub-
sections: 
‘‘(d)(1) With respect to a registrant under section 
1008 who is authorized under subsection (a)(1) to import 
ephedrine, pseudoephedrine, or phenylpropanolamine, at 
any time during the year the registrant may apply for an